May support reductions in fat mass while preserving lean muscle in animal models [8] [9]
Based on current clinical guidelines and our patient experience: Strong indication: BMI 30 (obesity) without active contraindications BMI 27 (overweight) with weight-related comorbidities such as hypertension, dyslipidaemia, type 2 diabetes, sleep apnoea, or fatty liver disease Patients who have attempted weight management through diet and exercise without sustained results Patients who have plateaued with other weight management interventions Relative indication (clinical judgement): BMI 25-27 with specific metabolic drivers (pre-diabetes, insulin resistance, PCOS) Patients preparing for weight-related surgery or other medical interventions Patients with specific body composition goals beyond BMI criteria Not indicated or contraindicated: Pregnancy, breastfeeding, or pregnancy planning within next 2 months Personal or family history of medullary thyroid cancer or MEN2 syndrome Personal history of pancreatitis Active severe gastroparesis or severe gastrointestinal disease BMI below 25 (cosmetic use for body contouring in normal-weight individuals is not appropriate) Eating disorder history GLP-1 use can be problematic for patients with restrictive eating patterns Frequently asked questions Is Ozempic "better" for weight loss than Wegovy
The presence of a five folds ion at 845.23 in A and a distinct 845.44 peak in B confirmed that only one amino acid in the tirzepatide sequence was converted into a D-amino acid
At Klinic, we specialize in medical weight loss programs that prioritize FDA-approved prescription medications
both provide protection, but one creates lasting resilience
Melanie is not flippant about where her drugs come from, nor is she careless with her medical decisions
